Publicaciones en las que colabora con Manuel Serrano Marugán (19)

2016

  1. G6PD protects from oxidative damage and improves healthspan in mice

    Nature Communications, Vol. 7

2010

  1. Normal proliferation and tumorigenesis but impaired pancreatic function in mice lacking the cell cycle regulator Sei1

    PLoS ONE, Vol. 5, Núm. 1

2009

  1. Anti-aging activity of the Ink4/Arf locus

    Aging Cell, Vol. 8, Núm. 2, pp. 152-161

2008

  1. Telomerase Reverse Transcriptase Delays Aging in Cancer-Resistant Mice

    Cell, Vol. 135, Núm. 4, pp. 609-622

2007

  1. Delayed ageing through damage protection by the Arf/p53 pathway

    Nature, Vol. 448, Núm. 7151, pp. 375-379

  2. Increased p53 gene dosage reduces neointimal thickening induced by mechanical injury but has no effect on native atherosclerosis

    Cardiovascular Research, Vol. 75, Núm. 4, pp. 803-812

  3. Normal cellular senescence and cancer susceptibility in mice genetically deficient in Ras-induced senescence-1 (Ris1)

    Oncogene, Vol. 26, Núm. 12, pp. 1673-1680

2006

  1. Increased p53 activity does not accelerate telomere-driven ageing

    EMBO Reports, Vol. 7, Núm. 5, pp. 546-552

  2. Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62

    Cell Metabolism, Vol. 3, Núm. 3, pp. 211-222

  3. Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma

    Oncogene, Vol. 25, Núm. 29, pp. 4128-4132

2005

  1. Tumour biology: Senescence in premalignant tumours

    Nature, Vol. 436, Núm. 7051, pp. 642

  2. Tumour-suppression activity of the proapoptotic regulator Par4

    EMBO Reports, Vol. 6, Núm. 6, pp. 577-583

2004

  1. Crosstalk between PKCζ and the IL4/Stat6 pathway during T-cell-mediated hepatitis

    EMBO Journal, Vol. 23, Núm. 23, pp. 4595-4605

  2. Different cooperating effect of p21 or p27 deficiency in combination with INK4a/ARF deletion in mice

    Oncogene, Vol. 23, Núm. 50, pp. 8231-8237

  3. Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging

    Genes and Development, Vol. 18, Núm. 22, pp. 2736-2746

  4. The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis

    Developmental Cell, Vol. 6, Núm. 2, pp. 303-309

2002

  1. 'Super p53' mice exhibit enhanced DNA damage response, are tumor resistant and age normally

    EMBO Journal, Vol. 21, Núm. 22, pp. 6225-6235

2001

  1. Tumor susceptibility of p21waf1/cip1-deficient mice

    Cancer Research, Vol. 61, Núm. 16, pp. 6234-6238

2000

  1. The cell cycle inhibitor p21 controls T-cell proliferation and sex- linked lupus development

    Nature Medicine, Vol. 6, Núm. 2, pp. 171-176